Thomas M Bridges

Title: Innovations of Thomas M Bridges

Introduction

Thomas M Bridges is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that act as positive allosteric modulators of the muscarinic acetylcholine receptor M4. With a total of 4 patents, his work has implications for treating neurological and psychiatric disorders.

Latest Patents

Bridges' latest patents include innovative tricyclic compounds such as pyrimido[4',5':4,5]thieno[2,3-c]pyridazine-8-amine and pyrido[3',2':4,5]thieno[3,2-d]pyrimidine-4-amine. These compounds are designed to enhance the function of the muscarinic acetylcholine receptor M4, which is crucial for various neurological functions. Additionally, he has developed methods for synthesizing these compounds and creating pharmaceutical compositions that can be used in treating disorders linked to receptor dysfunction.

Career Highlights

Bridges is affiliated with Vanderbilt University, where he conducts research and collaborates with other experts in the field. His work has been instrumental in advancing our understanding of receptor modulation and its potential therapeutic applications.

Collaborations

Some of his notable coworkers include Craig William Lindsley and P Jeffrey Conn. Their collaborative efforts have further enriched the research landscape in pharmacology and receptor biology.

Conclusion

Thomas M Bridges stands out as an influential inventor whose work in pharmacology is paving the way for new treatments for neurological disorders. His innovative compounds and collaborative research efforts continue to make a significant impact in the field.